About us

AuRA-AF is a national clinical quality registry (CQR) coordinated by Monash University and working in partnership with jurisdictions, healthcare providers, and peak clinical groups.

In conjunction with participating public and private hospitals, the registry aims to evaluate and improve clinical practice, ultimately enhancing outcomes and quality of care for patients undergoing ablation for AF.

Overview

Atrial fibrillation (AF) is the most common sustained cardiac arrythmia, affecting an estimated 60 million people globally as of 2019. In Australia, 2–3% of the population (more than 500,000 people) have AF and conservative estimates suggest this will be over 600,000 people by 2034. AF is the most common cardiac cause of hospitalisation, exceeding heart attack and heart failure, and impacts the physical, cognitive and psychosocial health of AF sufferers.

Success of AF ablation procedures depends on factors such as AF type, atrial dimensions, structural heart disease, and lifestyle risk factors such as obesity. AF ablation can reduce the recurrence of AF and the burden of disease. It can also improve the quality of life of patients by reducing symptoms and the need for medication.

AuRA-AF will collect highly standardised data about patients undergoing ablation for AF, including procedural information and information about patient outcomes, both short and long term.

The registry will provide hospitals and health care providers to benchmark performance against other health services and help drive improvements in AF treatment. It will enable important questions around improvements of care for patients of AF ablations across Australia.

Our team

Aims

The AuRA-AF registry aims to systematically monitor, evaluate, and improve the quality and safety of AF ablation procedures across Australia, by:

• Tracking procedural safety and efficacy
• Benchmark clinical outcomes and improve patient care
• Identify areas of excellence and opportunities for evidence-based improvement
• Identify population groups that may require better access to care
• Serve as a platform for research and innovation in AF treatment

Funding

The AuRA-AF registry has received grant funding from the Australian Government Medical Research Future Fund (MRFF). The registry also receives valuable and considerable in-kind support from its partner organisations.

Chief Investigators

Partner organisations